Publication | Closed Access

Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s Patients

Adverse Postoperative OutcomesGastroenterologyOutcomes ResearchPostoperative TreatmentSurgeryClinical GastroenterologyIleocolonic ResectionUlcerative ColitisMedicineAnesthesiology